Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Sales | 2,131 | 2,989 | 4,168 | 6,350 | 7,512 |
| Gross Profit | 2,131 | 2,989 | 4,168 | 6,350 | 7,512 |
| Operating Expenses | 23,888 | 25,771 | 27,738 | 27,239 | 32,334 |
| Operating Income | -21,757 | -22,782 | -23,570 | -20,889 | -24,822 |
| Interest Expense | 785 | 729 | 666 | 671 | 675 |
| Other Income | -228 | -31 | -101 | -8,942 | -2,901 |
| Pre-tax Income | -22,770 | -23,542 | -24,337 | -30,502 | -28,398 |
| Income Tax | -102 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -22,668 | -23,542 | -24,337 | -30,502 | -28,398 |
| Minority Interests | -3,526 | -3,469 | -2,777 | N/A | -4,939 |
| Net Income | $-19,142 | $-20,073 | $-21,560 | $-40,441 | $-18,459 |
| EPS Basic Total Ops | -0.98 | -1.05 | -1.12 | -0.77 | -1.19 |
| EPS Basic Continuous Ops | -1.16 | -1.20 | -1.24 | -1.56 | -1.45 |
| EPS Diluted Total Ops | -0.98 | -1.05 | -1.12 | -0.77 | -1.19 |
| EPS Diluted Continuous Ops | -1.16 | -1.20 | -1.24 | -1.56 | -1.45 |
| EBITDA(a) | $-19,779 | $-20,701 | $-21,263 | $-18,482 | $-22,358 |